Access this stock data via API
Subscribe
Genmab A/S
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 6.5B 5.9B 715M 743.8M
Cost of revenue 369.0M 362.6M 42M 40.4M
Gross profit 6.1B 5.5B 673M 703.4M
Operating expense
Research & development 2.3B 2.3B 359M 299.0M
Selling general and admin 941.6M 916.1M 126M 148.2M
Other operating expenses
Operating income 2.9B 2.3B 188M 256.3M
Non operating interest income
Income 203.6M 159.1M 33M 23.3M
Expense 19.1M 57.3M 5M 6.9M
Other income expense -38.2M 299.0M 28M 172.7M
Pretax income 3.1B 2.7B 244M 445.4M
Tax provision 515.3M 553.5M 49M -49.9M
Net income 2.6B 2.1B 195M 495.4M
Basic EPS 5.4 3.1
Diluted EPS 5.4 3.1
Basic average shares 393.0M 405.4M
Diluted average shares 394.4M 406.8M
EBITDA 3.2B 2.6B 237M 292.6M
Net income from continuing op. 3.1B 2.7B 244M 445.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 13 hours

19:59
00:00
09:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CET, UTC+01:00).